Lupin under USFDA glare for lapses at three plants
The issuance of Form 483 implies that the USFDA found certain procedural lapses and has sought corrective action from the company. The issuance of a warning letter -- which is more serious--implies that the company cannot export drugs manufactured at the facility to the US.
Mumbai-based drug major Lupin
Let’s apply Data-Driven Pricing to Your APIs
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions!
Learn More!